- Home
- ELEV vs RAYA Comparison
ELEV vs RAYA Comparison
Compare ELEV & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELEV
- RAYA
- Stock Information
- Founded
- ELEV 2019
- RAYA 2019
- Country
- ELEV United States
- RAYA China
- Employees
- ELEV N/A
- RAYA N/A
- Industry
- ELEV Biotechnology: Pharmaceutical Preparations
- RAYA Metal Fabrications
- Sector
- ELEV Health Care
- RAYA Consumer Discretionary
- Exchange
- ELEV Nasdaq
- RAYA Nasdaq
- Market Cap
- ELEV 22.0M
- RAYA 34.2M
- IPO Year
- ELEV 2021
- RAYA 2022
- Fundamental
- Price
- ELEV $0.36
- RAYA $1.32
- Analyst Decision
- ELEV Buy
- RAYA
- Analyst Count
- ELEV 6
- RAYA 0
- Target Price
- ELEV $2.94
- RAYA N/A
- AVG Volume (30 Days)
- ELEV 996.3K
- RAYA 22.2K
- Earning Date
- ELEV 05-16-2025
- RAYA 01-01-0001
- Dividend Yield
- ELEV N/A
- RAYA N/A
- EPS Growth
- ELEV N/A
- RAYA N/A
- EPS
- ELEV N/A
- RAYA N/A
- Revenue
- ELEV N/A
- RAYA $30,300,360.00
- Revenue This Year
- ELEV N/A
- RAYA $20.95
- Revenue Next Year
- ELEV N/A
- RAYA N/A
- P/E Ratio
- ELEV N/A
- RAYA N/A
- Revenue Growth
- ELEV N/A
- RAYA 49.10
- 52 Week Low
- ELEV $0.22
- RAYA $0.56
- 52 Week High
- ELEV $4.33
- RAYA $1.90
- Technical
- Relative Strength Index (RSI)
- ELEV 52.69
- RAYA 44.13
- Support Level
- ELEV $0.34
- RAYA $1.23
- Resistance Level
- ELEV $0.36
- RAYA $1.59
- Average True Range (ATR)
- ELEV 0.03
- RAYA 0.15
- MACD
- ELEV 0.00
- RAYA -0.04
- Stochastic Oscillator
- ELEV 50.00
- RAYA 14.75
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.
About RAYA Erayak Power Solution Group Inc.
Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from three products namely inverters, chargers, and gasoline generators. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.